Metabolites can serve as biomarkers for cancer diagnosis and prognosis. For example, elevated levels of prostate-specific antigen (PSA) metabolites in the blood are indicative of prostate cancer. Advanced techniques such as mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy are used to profile the metabolome of tumor tissues and biological fluids, helping to identify specific metabolic signatures associated with different cancer types.
